| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77d9bf55e6700374867763cc2c6acaff |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 |
| filingDate |
2005-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ed90f8b3162d88fb0fb5f34c31fe628
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4894666caf49e7470ae2959382882db6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b95a985ec4924e4b58db09c5a68222d8 |
| publicationDate |
2009-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7576189-B2 |
| titleOfInvention |
Antibodies to human vascular endothelial growth factor 2 and methods of using the same |
| abstract |
Disclosed is a human VEGF2 polypeptide and DNA(RNA) encoding such VEGF2 polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques and antibodies and antagonist against such polypeptide. Also disclosed is a method of using such polypeptide for stimulating wound healing and for vascular tissue repair. Also provided are methods of using the antagonists to inhibit tumor growth, inflammation and to treat diabetic retinopathy, rheumatoid arthritis and psoriasis. Diagnostic methods for detecting mutations in the VEGF2 coding sequence and alterations in the concentration of VEGF2 protein in a sample derived from a host are also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11209444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8784809-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014182635-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8206708-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011229466-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009317394-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9403905-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008286288-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8216569-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10274503-B2 |
| priorityDate |
1994-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |